Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 279

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Outpatient Talc Administration by Indwelling Pleural Catheter for Malignant Effusion

Open access
Bhatnagar, Rahul, Keenan, Emma K., Morley, Anna J., Kahan, Brennan C., Stanton, Andrew E., Haris, Mohammed, Harrison, Richard N., Mustafa, Rehan A., Bishop, Lesley J., Ahmed, Liju, West, Alex, Holme, Jayne, Evison, Matthew, Munavvar, Mohammed, Sivasothy, Pasupathy, Herre, Jurgen, Cooper, David, Roberts, Mark, Guhan, Anur, Hooper, Clare, Walters, James, Saba, Tarek S., Chakrabarti, Biswajit, Gunatilake, Samal, Psallidas, Ioannis, Walker, Steven P., Bibby, Anna C., Smith, Sarah, Stadon, Louise J., Zahan-Evans, Natalie J., Lee, Y.C. Gary, Harvey, John E., Rahman, Najib M., Miller, Robert F., Maskell, Nick A. · 2018 · New England Journal of Medicine

Abstract

BACKGROUND: Malignant pleural effusion affects more than 750,000 persons each year across Europe and the United States. Pleurodesis with the administration of talc in hospitalized patients is the most common treatment, but indwelling pleural catheters placed for drainage offer an ambulatory alternative. We examined whether talc administered through an indwelling pleural catheter was more effective at inducing pleurodesis than the use of an indwelling pleural catheter alone. METHODS: Over a period of 4 years, we recruited patients with malignant pleural effusion at 18 centers in the United Kingdom. After the insertion of an indwelling pleural catheter, patients underwent drainage regularly on an outpatient basis. If there was no evidence of substantial lung entrapment (nonexpandable lung, in which lung expansion and pleural apposition are not possible because of visceral fibrosis or bronchial obstruction) at 10 days, patients were randomly assigned to receive either 4 g of talc slurry or placebo through the indwelling pleural catheter on an outpatient basis. Talc or placebo was administered on a single-blind basis. Follow-up lasted for 70 days. The primary outcome was successful pleurodesis at day 35 after randomization. RESULTS: The target of 154 patients undergoing randomization was reached after 584 patients were approached. At day 35, a total of 30 of 69 patients (43%) in the talc group had successful pleurodesis, as compared with 16 of 70 (23%) in the placebo group (hazard ratio, 2.20; 95% confidence interval, 1.23 to 3.92; P=0.008). No significant between-group differences in effusion size and complexity, number of inpatient days, mortality, or number of adverse events were identified. No significant excess of blockages of the indwelling pleural catheter was noted in the talc group. CONCLUSIONS: Among patients without substantial lung entrapment, the outpatient administration of talc through an indwelling pleural catheter for the treatment of malignant pleural effusion resulted in a significantly higher chance of pleurodesis at 35 days than an indwelling catheter alone, with no deleterious effects. (Funded by Becton Dickinson; EudraCT number, 2012-000599-40 .).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa1716883

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 279

Metadata

Authors
Bhatnagar, R., Keenan, E. K., Morley, A. J., Kahan, B. C., Stanton, A. E., Haris, M., Harrison, R. N., Mustafa, R. A., Bishop, L. J., Ahmed, L., West, A., Holme, J., Evison, M., Munavvar, M., Sivasothy, P., Herre, J., Cooper, D., Roberts, M., Guhan, A., Hooper, C., Walters, J., Saba, T. S., Chakrabarti, B., Gunatilake, S., Psallidas, I., Walker, S. P., Bibby, A. C., Smith, S., Stadon, L. J., Zahan-Evans, N. J., Lee, Y. C. G., Harvey, J. E., Rahman, N. M., Miller, R. F., & Maskell, N. A.
Venue
New England Journal of Medicine
Published
2018-04-05
Volume
378
Issue
14
Pages
1313-1322
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2795716722
Cited by
279
References
22
FWCI
22.83
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.